4th Quarter - Report

CONSTANTINE CANNON, LLP for AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

Foreign entity interest: S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation

LobbyistCovered position, as disclosed
STEPHEN S ANDERSON —
W STEPHEN CANNON —
JOSEPH H GIBSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1298 (111th), S. 4018 (111th), S. 1292 (111th), H.R. 6165 (111th), H.R. 1191 (111th), S. 1336 (111th), S. 525 (111th), H.R. 1359 (111th), H.R. 5712 (111th)

Copyright/Patent/Trademark CPT

S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform

Foreign entity interest: S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform

LobbyistCovered position, as disclosed
STEPHEN S ANDERSON —
W STEPHEN CANNON —
JOSEPH H GIBSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 369 (111th), S. 515 (111th), H.R. 1706 (111th), H.R. 1260 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.